Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-044741
Filing Date
2013-09-18
Accepted
2013-09-18 16:23:45
Documents
1
Period of Report
2013-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3630
  Complete submission text file 0001209191-13-044741.txt   5143
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address
KARR ROBERT W (Reporting) CIK: 0001328507 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 131103790